Cardiometabolic index as a predictor of major adverse cardiovascular events in atrial fibrillation: insights from a community-based cohort
Elevated CMI is independently associated with increased MACE risk in patients with atrial fibrillation and demonstrates a nonlinear dose-response relationship. As a simple, accessible metabolic indicator, CMI shows promise for improving cardiovascular risk identification and guiding personalized management-especially in high-risk AF patients without overt metabolic dysfunction.
Authors
- Long Shen (ORCID: https://orcid.org/0000-0003-3395-3783)
- Mangmang Pan
- Zhi‐Chun Gu (ORCID: https://orcid.org/0000-0002-1245-9690)
- Hao Huang (ORCID: https://orcid.org/0000-0003-1748-1245)
- Siliang Zeng
- Jingjing Sha (ORCID: https://orcid.org/0000-0001-7823-6652)
- Caihong Liu (ORCID: https://orcid.org/0000-0002-8582-912X)
- Jiayue Cheng
- Xunhan Qiu
Institutions
- Shanghai Normal University (CN)
- Renji Hospital (CN)
- Community Health Center (US)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-10-03
- DOI
- https://doi.org/10.3389/fendo.2025.1682622
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Normal University
- Shanghai Jiao Tong University
- Renji Hospital